Literature DB >> 11232511

Iron-overload cardiomyopathy: evidence for a free radical--mediated mechanism of injury and dysfunction in a murine model.

W J Bartfay1, E Bartfay.   

Abstract

Iron-overload cardiomyopathy is a restrictive cardiomyopathy that manifests itself as systolic or diastolic dysfunction secondary to increased deposition of iron in the heart and occurs with common genetic disorders such as primary hemochromatosis and beta-thalassemia major. Although the exact mechanism of iron-induced heart failure remains to be elucidated, the toxicity of iron in biological systems is believed to be attributed to its ability to catalyze the generation of oxygen-free radicals. In the current investigation, the dose-dependent effects of chronic iron-loading on heart tissue concentrations of iron, glutathione peroxidase (GPx) activity, free-radical production, and cardiac dysfunction were investigated in a murine model of iron-overload cardiomyopathy. It was shown that chronic iron-overload results in dose-dependent (a) increases in myocardial iron burden, (b) decreases in the protective antioxidant enzyme GPx activity, (c) increased free-radical production, and (d) increased mortality. These findings show that the mechanism of iron-induced heart dysfunction involves in part free radical-mediated processes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11232511     DOI: 10.1177/109980040000200106

Source DB:  PubMed          Journal:  Biol Res Nurs        ISSN: 1099-8004            Impact factor:   2.522


  16 in total

1.  Mitochondrial dysfunction may explain the cardiomyopathy of chronic iron overload.

Authors:  Xueshan Gao; Mingwei Qian; Jian Li Campian; James Marshall; Zhanxiang Zhou; Andrew M Roberts; Y James Kang; Sumanth D Prabhu; Xiao-Feng Sun; John W Eaton
Journal:  Free Radic Biol Med       Date:  2010-05-05       Impact factor: 7.376

2.  Blockade of angiotensin AT1 receptors prevents arterial remodelling and stiffening in iron-overloaded rats.

Authors:  Helbert Gabriel Fidelis; Jandinay Gonzaga Alexandre Mageski; Susana Curry Evangelista Goes; Tatiani Botelho; Vinicius Bermond Marques; Renata Andrade Ávila; Leonardo Dos Santos
Journal:  Br J Pharmacol       Date:  2020-01-03       Impact factor: 8.739

Review 3.  Electrocardiographic Presentation, Cardiac Arrhythmias, and Their Management in β-Thalassemia Major Patients.

Authors:  Vincenzo Russo; Anna Rago; Andrea Antonio Papa; Gerardo Nigro
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-06-20       Impact factor: 1.468

4.  Astragalus polysaccharides meliorate cardiovascular dysfunction in iron-overloaded thalassemic mice.

Authors:  Xue Yang; Xiaoxi Zhu; Xianying Tang; Mei Liu; Huiling Zheng; Lin Zheng
Journal:  Exp Biol Med (Maywood)       Date:  2019-09-12

Review 5.  Involvement of cytosolic and mitochondrial iron in iron overload cardiomyopathy: an update.

Authors:  Richard Gordan; Suwakon Wongjaikam; Judith K Gwathmey; Nipon Chattipakorn; Siriporn C Chattipakorn; Lai-Hua Xie
Journal:  Heart Fail Rev       Date:  2018-09       Impact factor: 4.214

Review 6.  Cardiac iron across different transfusion-dependent diseases.

Authors:  John C Wood
Journal:  Blood Rev       Date:  2008-12       Impact factor: 8.250

7.  Iron excretion in iron dextran-overloaded mice.

Authors:  Marco Musumeci; Sonia Maccari; Alessia Massimi; Tonino Stati; Paola Sestili; Elisa Corritore; Augusto Pastorelli; Paolo Stacchini; Giuseppe Marano; Liviana Catalano
Journal:  Blood Transfus       Date:  2014-06-05       Impact factor: 3.443

Review 8.  Iron overload thalassemic cardiomyopathy: iron status assessment and mechanisms of mechanical and electrical disturbance due to iron toxicity.

Authors:  Suree Lekawanvijit; Nipon Chattipakorn
Journal:  Can J Cardiol       Date:  2009-04       Impact factor: 5.223

9.  The Association between Myocardial Iron Load and Ventricular Repolarization Parameters in Asymptomatic Beta-Thalassemia Patients.

Authors:  Mehmet Kayrak; Kadir Acar; Enes Elvin Gul; Orhan Ozbek; Turyan Abdulhalikov; Osman Sonmez; Hajrudin Alibaşiç
Journal:  Adv Hematol       Date:  2012-05-15

10.  Correction of the iron overload defect in beta-2-microglobulin knockout mice by lactoferrin abolishes their increased susceptibility to tuberculosis.

Authors:  Ulrich E Schaible; Helen L Collins; Friedrich Priem; Stefan H E Kaufmann
Journal:  J Exp Med       Date:  2002-12-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.